Latest News

Bio Innovations Europe 2026: Driving the Commercialisation of Industrial Biomanufacturing

InnoSyn B.V. will attend Bio Innovations Europe 2026, taking place on ...

WO2026002830 - A Scalable Process for the Manufacture of 2,2-Bis(Aminomethyl)Propane-1,3-Diamine Tetrahydrochloride

InnoSyn Inventors: HERMSEN, Petrus and DIELEMANS, Hubertus

Process Development and Scale-Up of a Novel Route to 8-Aminooctanoic Acid

The development of robust and scalable synthetic routes remains a crit...

InnoSyn BV and SynSilico Join Forces in Enzyme Engineering

Cryogenic Flow Chemistry Made Easy

17 march 2020 - The Skid concept for pilot plant scale...

InnoSyn at CPHI and BioEurope 2024

InnoSyn recently participated in two of the year’s biggest industry ev...

AI Meets Chemistry: InnoSyn and Genzai Create SynSilico for Revolutionary R&D

InnoSyn and Genzai have jointly announced the formation of SynSilico, ...

Dr. Iwona Kaluzna Joining the InnoSyn Management Team

It is our great pleasure to announce that per January 1st 2023, Iwona ...

Macrocyclic Baeyer-Villiger Monooxygenase Oxidation of Cyclopentadecanone on 1 L Scale

“In the last couple of years our Biocatalysis team at @InnoSyn was ver...

Mérieux Equity Partners to partner with – through acquiring a majority stake in – InnoSyn, a leading European provider of outsourced process R&D services, located in the Netherlands

Paris, France – January 29th, 2024 – **Mérieux Equity Partners (“MxEP”...

Enzymatic Supply and Recycling of High-value Co-substrates and Co-factors for Industrial Biocatalysis

Enzymes catalysis an astonishing variety of chemistries and for this r...